Metal-phenolic nanozyme as a ferroptosis inhibitor for alleviating cisplatin-induced acute kidney injury
IntroductionCisplatin-induced acute kidney injury (AKI) is primarily caused by oxidative stress from reactive oxygen species (ROS) accumulation. Developing ROS scavengers presents promising opportunities for preventing and treating this condition by targeting oxidative stress mechanisms.MethodsThis...
Saved in:
| Main Authors: | Yunfeng Xiong, Huimin Kang, Yanping Rao, Xiayu Huang, Yang Zhu, Lixin Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1535969/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The protective effects of FeOx/NC nanozymes on chondrocytes by scavenging reactive oxygen species
by: Jianfeng GUO, et al.
Published: (2025-06-01) -
Single-atom nanozyme-mediated dihydroartemisinin delivery for self-enhanced chemodynamic therapy and ferroptosis
by: Yuanlong Zhang, et al.
Published: (2025-10-01) -
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer’s disease
by: Jing Ma, et al.
Published: (2025-03-01) -
Bimetallic Plasmonic Nanozyme‐Based Microneedle for Synergistic Ferroptosis Therapy of Melanoma
by: Wei Duan, et al.
Published: (2025-08-01) -
Reserpine alleviates cisplatin-induced acute kidney injury via anti-ferroptosis and cGAS/STING pathway
by: Nahua Xu, et al.
Published: (2024-12-01)